Polycom RealPresence Platform Further Revolutionises Collaboration and User Experiences with Three New Solutions
Polycom has announced at InfoComm 2015 three new solutions to its industry-leading RealPresence Platform.Polycom added...
Biopharma R&D, from drug discovery through to late phase clinical trials, suffers from two fundamental, near industry-threatening problems: it is too slow and too expensive.
With payers and the public getting increasingly vocal about drug prices, the long-standing tactic of passing on costs to the healthcare system is precarious.
Download to find out more.
Polycom has announced at InfoComm 2015 three new solutions to its industry-leading RealPresence Platform.Polycom added...
Where and how people work is changing and IT departments must meet the demands of...
More than 95% of companies Polycom spoke to said innovation using collaboration is important to...